Works matching IS 0195668X AND DT 2020 AND VI 41 AND IP 2
Results: 22
A revolution in diabetes care: novel drugs and new recommendations.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 195, doi. 10.1093/eurheartj/ehz966
- By:
- Publication type:
- Article
New EHJ International Editorial Board Member.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 208, doi. 10.1093/eurheartj/ehz937
- Publication type:
- Article
IRIS courses for cardiology: IRIS courses are available in 2020 which are designed for building a research career in cardiology.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 207, doi. 10.1093/eurheartj/ehz936
- By:
- Publication type:
- Article
Cardiology care delivered to cancer patients: The results of a questionnaire survey by the Council for Cardio Oncology and Council for Cardiology Practice of the European Society of Cardiology.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 205, doi. 10.1093/eurheartj/ehz935
- By:
- Publication type:
- Article
The Fourth European-South African Cardiovascular Research Workshop: Strengthening cardiovascular research networking between the southern and northern hemispheres.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 203, doi. 10.1093/eurheartj/ehz934
- By:
- Publication type:
- Article
Animals in cardiovascular research: Clinical relevance and translational limitations of animal models in cardiovascular medicine.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 200, doi. 10.1093/eurheartj/ehz933
- By:
- Publication type:
- Article
Vera Regitz-Zagrosek MD PhD: A cardiologist and Professor of Gender Medicine, Vera Regitz-Zagrosek has been appointed the Anna Fischer-Dückelmann Visiting Professor at the University of Zurich, Switzerland.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 199, doi. 10.1093/eurheartj/ehz932
- By:
- Publication type:
- Article
Compelling evidence for SGLT2 inhibitors and GLP-1 receptor agonists as first-line therapy in patients with diabetes at very high/high cardiovascular risk.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 329, doi. 10.1093/eurheartj/ehz853
- By:
- Publication type:
- Article
Treatment algorithm in patients with type 2 diabetes and atherosclerotic cardiovascular disease or high/very high cardiovascular risk.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 331, doi. 10.1093/eurheartj/ehz831
- By:
- Publication type:
- Article
Amphetamine-induced coronary artery dissection and massive aortic valve thrombus.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 230, doi. 10.1093/eurheartj/ehz829
- By:
- Publication type:
- Article
Complete regression of coronary atherosclerosis.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 332, doi. 10.1093/eurheartj/ehz792
- By:
- Publication type:
- Article
Comments on the 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 328, doi. 10.1093/eurheartj/ehz777
- By:
- Publication type:
- Article
A tip of the CAP1 to cholesterol metabolism.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 253, doi. 10.1093/eurheartj/ehz771
- By:
- Publication type:
- Article
A new perspective on lowering CV risk from hypoglycaemia.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 218, doi. 10.1093/eurheartj/ehz730
- By:
- Publication type:
- Article
Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME<sup>®</sup> trial.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 209, doi. 10.1093/eurheartj/ehz621
- By:
- Publication type:
- Article
Obesity causes cardiovascular diseases: adding to the weight of evidence.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 227, doi. 10.1093/eurheartj/ehz569
- By:
- Publication type:
- Article
Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 239, doi. 10.1093/eurheartj/ehz566
- By:
- Publication type:
- Article
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 255, doi. 10.1093/eurheartj/ehz486
- By:
- Publication type:
- Article
Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 221, doi. 10.1093/eurheartj/ehz388
- By:
- Publication type:
- Article
Response to 'The possible role of insulin and glucagon in patients with heart failure and Type 2 diabetes'.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 326, doi. 10.1093/eurheartj/ehz243
- By:
- Publication type:
- Article
The possible role of insulin and glucagon in patients with heart failure and Type 2 diabetes.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 325, doi. 10.1093/eurheartj/ehz242
- By:
- Publication type:
- Article
Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 231, doi. 10.1093/eurheartj/ehy808
- By:
- Publication type:
- Article